Ratings by William Blair (Brian Weinstein)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/21/2025 | Hologic | HOLX | Downgrade | Market Perform (Outperform) |
71.87 (76.01) |
5.76% | Details | |
| 5/14/2025 | Biodesix | BDSX | Downgrade | Market Perform (Outperform) |
0.36 (12.93) |
3491.67% | Details | |
| 5/1/2025 | Becton Dickinson | BDX | Downgrade | Market Perform (Outperform) |
207.09 (146.24) |
-29.38% | Details | |
| 7/15/2022 | 10X Genomics | TXG | Downgrade | Market Perform (Outperform) |
43.29 (19.48) |
-55% | Details | |
| 7/7/2022 | Meridian Biosciences | VIVO | Maintain | Market Perform (Outperform) |
|
Details | ||
| 2/3/2022 | Glaukos Corporation | GKOS | Upgrade | Outperform (Market Perform) |
52.90 (126.81) |
139.72% | Details | |
| 8/9/2021 | Sera Prognostics Inc | SERA | New Coverage | Outperform (N/A) |
12.89 (1.87) |
-85.49% | Details | |
| 7/14/2021 | Glaukos Corporation | GKOS | Downgrade | Market Perform (Outperform) |
77.00 (126.81) |
64.69% | Details | |
| 5/4/2021 | Lucira Health Inc. | LHDX | Downgrade | Market Perform (Outperform) |
6.26 (0.45) |
-92.81% | Details | |
| 3/15/2021 | 10X Genomics | TXG | New Coverage | Outperform (N/A) |
160.02 (28.84) |
-81.98% | Details | |
| 3/2/2021 | Lucira Health Inc. | LHDX | New Coverage | Outperform (N/A) |
19.39 (0.45) |
-97.68% | Details | |
| 1/12/2021 | 908 Devices Inc. | MASS | New Coverage | Outperform (N/A) |
56.63 (8.27) |
-85.4% | Details | |
| 11/23/2020 | Biodesix | BDSX | New Coverage | Outperform (N/A) |
17.09 (0.36) |
-97.89% | Details | |
| 2/6/2020 | Becton Dickinson | BDX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/21/2019 | Hologic | HOLX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | AxoGen, Inc. | AXGN | Downgrade | Market Perform (Outperform) |
17.58 (43.00) |
144.6% | Details | |
| 7/22/2019 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Outperform (N/A) |
38.01 (17.60) |
-53.7% | Details | |
| 3/19/2019 | Becton Dickinson | BDX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2018 | Guardant Health | GH | New Coverage | Outperform (N/A) |
35.14 (131.62) |
274.56% | Details | |
| 9/11/2018 | Invuity | IVTY | Downgrade | Market Perform (Outperform) |
5.75 (7.39) |
28.52% | Details | |
| 8/29/2018 | Glaukos Corporation | GKOS | Maintain | Outperform (N/A) |
|
Details |
